4.6 Article

Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review

Maryam Nabati et al.

Summary: Remdesivir is currently the only authorized drug for COVID-19 treatment under emergency circumstances, but it may have cardiotoxic and proarrhythmic effects, especially more pronounced in patients with a history of cardiovascular diseases. Further clinical trials are needed to fully understand its safety profile and potential adverse cardiovascular effects.

CARDIOVASCULAR TOXICOLOGY (2022)

Article Cell Biology

Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons

Ching Ying Huang et al.

Summary: In this study, a population-based hiPSC drug screening platform is established to assess toxicity. Thirteen HLA-homozygous super donors are identified after recruiting 1,000 healthy donors and screening for high-frequency HLA haplotypes, representing at least 477,611,135 of the global population. The differentiated hiPSCs into cardiomyocytes and neurons demonstrate their utility in a high-throughput toxicity screen. Dose-dependent toxicity and functional modulation of hit compounds are validated, and reproducible in vivo drug toxicity results using mouse models are shown. This study shows the feasibility of using a population-based hiPSC drug screening platform to study inter population differences in drug toxicity and adverse drug reactions.

CELL REPORTS (2022)

Review Otorhinolaryngology

Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence

Esmaeil Mehraeen et al.

Summary: Studies have shown a significant increase in olfactory and gustatory dysfunctions during the COVID-19 epidemic. Most studies (95.8%) have confirmed symptoms of anosmia in patients with SARS-CoV-2 infection, along with evidence of ageusia and dysgeusia in patients with COVID-19. The findings support reports that SARS-CoV-2 may infect oral and nasal tissues, leading to olfactory and gustatory dysfunctions.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Clinical Neurology

Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection

Rafal Butowt et al.

Summary: The prevalence of smell and taste dysfunction in COVID-19 differs between populations, possibly due to differences in virus strains or host proteins. Recent progress has been made in defining the cellular and molecular mechanisms of virus-induced anosmia, focusing on the role of sustentacular cells in the olfactory epithelium. The potential for using smell and taste dysfunctions as early diagnostic tools in COVID-19 is discussed.

NEUROSCIENTIST (2021)

Article Rheumatology

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Angel Y. S. Wong et al.

Summary: Two cohort studies were conducted to assess the association between routinely prescribed NSAIDs and COVID-19 related deaths, finding no evidence of a harmful effect. Therefore, the risks of COVID-19 do not need to influence decisions about the routine therapeutic use of NSAIDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Cardiac & Cardiovascular Systems

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients

Seyed Parsa Eftekhar et al.

Summary: The study found no significant difference in QT interval prolongation among COVID-19 patients treated with hydroxychloroquine with or without azithromycin, but 22.1% of patients showed prolonged QT interval after treatment. Male gender, baseline QTc >= 450 milliseconds, or high-risk Tisdale score increased the likelihood of prolonged QT interval. Careful cardiac monitoring is required during therapy, especially for high-risk patients.

CARDIOVASCULAR THERAPEUTICS (2021)

Review Pharmacology & Pharmacy

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

Rita Humeniuk et al.

Summary: Remdesivir is an approved treatment for severe COVID-19 in adults and children, with a dosing regimen based on pharmacokinetic and safety evaluations. Predictions suggest low potential for drug-drug interactions and efficient conversion to the active form for effective treatment.

CLINICAL PHARMACOKINETICS (2021)

Article Cell Biology

SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19

Juan A. Perez-Bermejo et al.

Summary: This study found that heart cells of COVID-19 patients exposed to SARS-CoV-2 may suffer significant damage such as myofibrillar fragmentation and nuclear disruption, providing insights for potential therapeutic discovery.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Mark Dittmar et al.

Summary: There is an urgent need for antiviral drugs to treat SARS-CoV-2, and screening has identified several potential candidates with different mechanisms of action in lung epithelial cells. Some of these drugs could be used for the treatment of respiratory cells in patients.

CELL REPORTS (2021)

Article Toxicology

Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Shota Yanagida et al.

Summary: This study focused on assessing the cardiotoxicity risk of COVID-19 treatments using hiPSC-CMs, finding that hydroxychloroquine poses a proarrhythmic risk while other drugs have low risks. Therefore, hiPSC-CMs may be a useful tool for evaluating the comprehensive cardiotoxicity caused by COVID-19 treatments in nonclinical settings.

TOXICOLOGICAL SCIENCES (2021)

Article Public, Environmental & Occupational Health

Arbidol is associated with increased in-hospital mortality among 109 patients with severe COVID-19: A multicenter, retrospective study

Xianlong Zhou et al.

Summary: This study found that LPV/r, IFN-a, ribavirin, or oseltamivir have no beneficial effects on the prognosis of severe COVID-19 patients, whereas the use of arbidol is associated with increased in-hospital mortality.

JOURNAL OF GLOBAL HEALTH (2021)

Review Clinical Neurology

The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review

Sanghamithra Ramani et al.

Summary: The relationship between neurofilament light chain (NfL) levels and cognition is generally inverse, with higher NfL levels associated with poorer cognition. However, this relationship varies across different neurological disorders, possibly due to individual differences or methodological inconsistencies. Further research is needed to clarify this relationship and recommendations for future investigations have been suggested.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Review Immunology

Nervous system involvement after infection with COVID-19 and other coronaviruses

Yeshun Wu et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

Luka Nicin et al.

EUROPEAN HEART JOURNAL (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al.

JAMA CARDIOLOGY (2020)

Article Medicine, Research & Experimental

Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19

Simona Pisanti et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Review Cell & Tissue Engineering

Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology

Camille R. Simoneau et al.

CELL STEM CELL (2020)

Review Medicine, General & Internal

severe Acute Respiratory Syndrome Coronavirus-2 SARS-CoV-2 An Update

Mahendra Pal et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Editorial Material Cardiac & Cardiovascular Systems

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

Luka Nicin et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories

Hyun Seok Hwang et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)

Article Pharmacology & Pharmacy

Pharmacokinetics of single and multiple oral doses of arbidol in healthy Chinese volunteers

Yaxin Sun et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)

Review Cardiac & Cardiovascular Systems

Safety and efficacy of statins in Asians

James K. Liao

AMERICAN JOURNAL OF CARDIOLOGY (2007)

Article Pharmacology & Pharmacy

The influence of ethnicity on warfarin dosage requirement

MTN Dang et al.

ANNALS OF PHARMACOTHERAPY (2005)